Daliresp 500 MCG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26FZ75K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,580
Award facts
- Contract value 100% obligated
- $54,579.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for $54.6K on November 18, 2025, with an ultimate completion date of November 19, 2025. The contract involves the supply of Daliresp (roflumilast) 500 mcg tablets in quantities of 90, utilizing firm fixed price pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.9M through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally.
This award demonstrates AmerisourceBergen's continued role as a critical vendor within the Defense Health Agency supply chain, providing specialized pharmaceutical products to support federal medical procurement needs. The company's extensive portfolio includes brand-name and generic medications across multiple therapeutic domains, with consistent delivery orders featuring firm fixed pricing structures. The contract reflects the Defense Logistics Agency's reliance on established prime vendors to efficiently fulfill pharmaceutical requirements for military and veteran healthcare systems, leveraging framework agreements that enable rapid procurement of essential medical commodities.
Quick answers
Who was awarded contract SPE2DR26FZ75K?
SPE2DR26FZ75K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FZ75K worth?
The government has obligated $54,580 on SPE2DR26FZ75K.
Is contract SPE2DR26FZ75K an order under another contract?
Yes. SPE2DR26FZ75K is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ75K competed?
The extent of competition for SPE2DR26FZ75K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award